Cigna Corporation ($CI) Stock Forecast: Up 0.4% Today

What is Cigna Corporation?

Cigna Group (NYSE: CI) Market: Cigna Group displayed a strong bullish movement today amidst the following market conditions: Rockwell Automation surpassed profit and sales estimates but adjusted its full-year profit forecast slightly, leading to a minor decrease in its shares. KKR and Cummins Inc. announced mixed Q4 earnings, with KKR exceeding revenue expectations and Cummins encountering an EPS shortfall. Express Scripts, a Cigna Corp subsidiary, reached a settlement with the FTC regarding insulin pricing practices to reduce drug costs for patients, insurers, and pharmacies.

Why is Cigna Corporation going up?

CI stock is up 0.4% on Feb 5, 2026 15:28

• Cigna Group's bullish momentum may stem from its positive earnings release, outperforming revenue and EPS expectations, indicating robust financial performance.
• The resolution of Express Scripts' issues with the FTC concerning insulin pricing practices might have enhanced investor trust in Cigna's dedication to ethical business conduct and cost-saving initiatives.
• Despite varied earnings results from other market players, Cigna's strategic direction and emphasis on cutting drug expenses appear to have resonated positively with investors, propelling the upward movement in its stock.

CI Price Chart

CI Technical Analysis

CI News

Rockwell Automation results top estimates, annual profit forecast lags

Rockwell Automation exceeded first-quarter profit and sales estimates, driven by industrial demand and cost-saving measures, which boosted its operating margin to 20.7%. However, the company's narrowed full-year profit forecast, with a midpoint below Wall Street estimates, caused its shares to fall. Rockwell uplifted the lower end of its adjusted profit forecast for 2026 to between $11.40 and $12.20 per share, while benefiting from U.S. reshoring and increased investment in automation and AI.

https://www.marketscreener.com/news/rockwell-automation-results-top-estimates-annual-profit-forecast-lags-ce7e5ad8d989f127

Q4 Earnings: KKR and Cummins Miss EPS, Cigna Beats

KKR and Cummins Inc. reported mixed Q4 2025 earnings, with KKR's revenue surpassing expectations despite a slight EPS miss, and Cummins facing an EPS shortfall due to strategic charges despite exceeding revenue forecasts. Conversely, The Cigna Group posted strong results, beating both revenue and EPS expectations. All three companies have outlined positive outlooks and strategic priorities for 2026, including acquisitions, efficiency improvements, and increased shareholder returns.

https://tokenist.com/q4-earnings-kkr-and-cummins-miss-eps-cigna-beats/

The Cigna Group's Fourth Quarter 2025 Earnings Release Details

The Cigna Group (NYSE: CI) will release its fourth-quarter 2025 financial results on Thursday, February 5, 2026, no later than 6:30 a.m. ET. Management will then host a conference call at 8:30 a.m. ET to review these results. A live internet webcast and a replay of the call will also be available for investors.

https://www.easternprogress.com/the-cigna-groups-fourth-quarter-2025-earnings-release-details/article_29e18c8b-265c-568b-8067-75f64c86538f.html

Express Scripts Reaches Deal With FTC Over Insulin Pricing Practices

Cigna Corp's pharmacy benefits arm, Express Scripts, has reached a settlement with the US Federal Trade Commission regarding allegations that its insulin pricing methods violated antitrust and consumer protection rules. The agreement aims to reduce prescription drug costs for patients, health plans, and independent pharmacies, and includes changes like limiting business practices that critics say drive up prices. The FTC believes these changes could save patients as much as $7 billion over the next decade.

https://www.pymnts.com/cpi-posts/express-scripts-reaches-deal-with-ftc-over-insulin-pricing-practices/

Cigna settles FTC insulin case, aims to lower drug prices

Cigna's Express Scripts has settled claims with the U.S. Federal Trade Commission regarding its insulin pricing practices, agreeing to changes aimed at lowering costs for patients, insurers, and pharmacies. The 10-year agreement restricts Express Scripts' ability to profit from rebates based on list prices and requires an independent monitor to oversee compliance, with an estimated savings of up to $7 billion for patients. This settlement allows the FTC to resolve a case brought by the former Biden administration, while cases against UnitedHealth Group's Optum and CVS Health Corp's CVS Caremark continue.

https://kfgo.com/2026/02/04/exclusive-cigna-settles-ftc-insulin-case-commits-to-overhauling-drug-pricing/

Trending Today

Cummins Inc. ($CMI) Stock Forecast: Down 6.8% Today

fuboTV Inc. ($FUBO) Stock Forecast: Up 5.1% Today

QUALCOMM Incorporated ($QCOM) Stock Forecast: Down 6.6% Today

Reddit Inc ($RDDT) Stock Forecast: Up 5.2% Today

QTUM ($QTUM) Crypto Forecast: Down 10.9% Today

MKS Instruments Inc. ($MKSI) Stock Forecast: Up 5.8% Today

Credo Technology Group ($CRDO) Stock Forecast: Up 5.5% Today

Quanta Services Inc. ($PWR) Stock Forecast: Up 5.1% Today

McKesson Corporation ($MCK) Stock Forecast: Up 13.6% Today

Upwork Inc. ($UPWK) Stock Forecast: Up 5.1% Today

Cigna Corporation Price History

07.00.2026 - CI Stock was down 3.1%

• The bearish movement in CI's stock could be attributed to negative developments impacting major healthcare conglomerates like CVS, UnitedHealth, and Cigna, accused of financial misconduct through secretive PBM Group Purchasing Organizations (GPOs).
• Concerns about ethical standards and financial transparency within the health insurance industry, prompted by the exposure of these practices, led to a loss in investor confidence and a decline in CI's stock price.
• The investigation revealing how these companies allegedly mishandle funds meant for health plans and patients raised worries about potential regulatory consequences and the sustainability of CI’s business model.
• Distrust and scrutiny towards the healthcare giants involved in questionable practices overshadowed CI's stock performance, contributing to the observed bearish trend.

30.00.2025 - CI Stock was down 8.9%

• Cigna's stock declined today following a Q4 earnings miss, with adjusted earnings per share falling below analyst forecasts.
• Although the reported revenue exceeded expectations, the lower-than-expected earnings per share was a disappointment for investors.
• By acknowledging the current challenges and outlining plans for improvement, Cigna demonstrates proactive efforts to address issues and potentially restore investor trust in the future.

02.00.2026 - CI Stock was up 1.8%

• The bullish movement in CI stock today could be attributed to positive news surrounding a new deal between Cigna and Tenet Healthcare Corp in Florida. This deal ensures continued in-network access for policyholders, potentially avoiding higher out-of-network costs and boosting investor confidence in CI.
• The inclusion of healthcare stocks, like CI, in a list of top 10 stock picks by a major financial institution, emphasizing diverse catalysts such as healthcare legislation, may have also contributed to the positive market sentiment in the healthcare sector.
• Despite certain pressures on another healthcare stock, CI's bullish movement today might suggest that investors perceive it to be better positioned to address challenges related to Medicare Advantage and rising medical costs effectively.
• The favorable outlook for healthcare stocks, supported by recommendations and market performance, likely influenced the bullish movement observed in CI today.

05.00.2026 - CI Stock was up 1.8%

• The bullish movement in CI's stock could be attributed to positive comments made by a hedge fund manager regarding another healthcare company, highlighting its undervaluation and long-term growth potential. This optimistic outlook on a competitor in the insurance industry may have positively impacted CI's stock.
• Additionally, the overall positive performance of managed-care peers, with a focus on upcoming earnings reports and operational reviews, could have created a favorable sentiment in the healthcare sector, benefiting CI as well.
• The resignation of a board member from another company may have had a minimal impact on CI's market movement, as investors were more likely focused on the positive news and outlook within the healthcare industry.
• A financial institution's top stock picks for Q1 2026, particularly in the healthcare sector, with diverse catalysts and strong performance indicators, could have further boosted investor confidence in CI and contributed to its bullish movement.

31.09.2024 - CI Stock was up 3.1%

• CI's strong bullish movement today could be attributed to the anticipation of positive Q3 earnings, driven by the performance of its Evernorth unit.
• The expected benefit from the strength in the specialty pharmacy business might have contributed to investor optimism, leading to the bullish market movement.
• Despite concerns about elevated medical costs due to higher utilization trends, the market seems to be focusing more on the potential growth prospects for CI in the upcoming earnings report.

04.01.2026 - CI Stock was up 1.6%

• The bullish movement in CI's stock could be attributed to the negative financial headwinds faced by major healthcare players like UnitedHealth, CVS, and Humana. As these competitors face profit pressures from proposed Medicare cuts and new regulations impacting their business segments, investors might see Cigna as a more stable and potentially profitable investment option within the healthcare sector.
• The dual pressure on UnitedHealth, CVS, and Humana from negligible Medicare Advantage payment increases and demands for transparency from PBMs could lead investors to seek alternative healthcare stocks like CI, driving up its value.
• With the potential squeeze on profits for competitors due to regulatory changes, investors may view CI as a more attractive investment opportunity, leading to the bullish movement in the stock price today.

02.04.2025 - CI Stock was down 2.1%

• The strong Q1 earnings and increased outlook suggest that Cigna's growth platforms are performing well.
• The bearish movement in the stock could be attributed to profit-taking by investors following a period of strong performance.
• Market sentiment may have been influenced by external factors or concerns about future growth potential despite the positive earnings.
• Some investors may have anticipated even higher earnings or guidance, prompting a sell-off in the stock.

31.00.2025 - CI Stock was up 6.0%

• Despite reporting lower-than-expected earnings for Q4, Cigna's stock experienced a bullish movement.
• The positive market reaction may be linked to the company's proactive approach to addressing the earnings miss and implementing corrective measures.
• Investors seem to be optimistic about the revenue beat, indicating growth potential for Cigna in the future.
• The uptick in the stock price could be influenced by general market sentiment or external factors benefiting the healthcare sector.

05.01.2024 - CI Stock was up 5.1%

• Cantor Fitzgerald raised Cigna to overweight and increased its target price, indicating positive sentiment towards the stock.
• Cigna reported strong Q4 results, beating profit and sales estimates, and provided strong guidance. This likely contributed to the bullish movement.
• The company also raised its dividend and experienced membership growth, further boosting investor confidence.
• The overall positive market sentiment, driven by expectations of a Fed pivot and strong economic growth, may have also played a role in the bullish movement of Cigna stock.

06.00.2026 - CI Stock was down 0.0%

• Stanley Laman Group Ltd. selling a significant portion of its holdings in Healthcare Services Group, Inc. (HCSG) might have raised concerns about the overall healthcare sector, impacting CI negatively.
• Positive comments on Molina Healthcare, Inc. (MOH) as a potentially undervalued player in the industry could have shifted investor focus away from CI.
• UnitedHealth Group Incorporated's positive performance and upcoming earnings report may have drawn attention and investment away from CI, contributing to its bearish movement.
• The resignation of Andrew Teno from Southwest Gas Holdings Inc. (SWX) board might have had a minor indirect impact on CI, as it could have influenced market sentiment towards related healthcare stocks.

03.09.2025 - CI Stock was up 4.7%

• The uptick in short interest may suggest a pessimistic outlook on Cigna Group among investors.
• Despite the growth in short interest, there is a sense of optimism regarding the company's future growth prospects and profitability.
• The positive movement in CI's stock price today could be connected to strong earnings results or strategic business advancements that have inspired confidence in investors.
• The market may be reevaluating the company's worth and potential for growth, leading to heightened buying activity and an increase in the stock price.

05.01.2026 - CI Stock was up 0.4%

• Cigna Group's bullish momentum may stem from its positive earnings release, outperforming revenue and EPS expectations, indicating robust financial performance.
• The resolution of Express Scripts' issues with the FTC concerning insulin pricing practices might have enhanced investor trust in Cigna's dedication to ethical business conduct and cost-saving initiatives.
• Despite varied earnings results from other market players, Cigna's strategic direction and emphasis on cutting drug expenses appear to have resonated positively with investors, propelling the upward movement in its stock.